Company: IMCR
Filing Date: 2025-03-17
Form Type: 424B7
Source: 0001140361-25-008917
Chunk: 10

Company: Immunocore Holdings plc
Filing Date: 2025-03-17
Form: 424B7
Chunk 10
---
 been received in respect of such Relevant Payments in the absence of such withholding or deduction. See “Description of Notes—Additional Amounts.” Fundamental Change If we undergo a “fundamental change” (as defined in the section titled “Description of Notes—Fundamental Change Permits Holders to Require Us to Repurchase Notes”), then, subject to certain conditions and except as described in this prospectus supplement, holders may require us to repurchase for cash all or any portion of their notes in principal amounts of $1,000 or an integral multiple thereof. The fundamental change repurchase price will be equal to 100% of the principal amount of the notes to be repurchased, plusaccrued and unpaid interest to, but excluding, the fundamental change repurchase date. See the section titled “Description of Notes—Fundamental Change Permits Holders to Require Us to Repurchase Notes.” Ranking The notes are our general unsecured obligations and rank:

| • | senior in right of payment to all of our indebtedness that is expressly subordinated in right of payment to the notes; |

| • | equal in right of payment with all of our existing and future liabilities that are not so subordinated; |

| • | effectively junior to any of our secured indebtedness to the extent of the value of the assets securing such indebtedness; and |

| • | structurally junior to all indebtedness and other liabilities (including trade payables) of our current or future subsidiaries. |

As of December 31, 2024, the outstanding principal amount of our consolidated indebtedness for borrowed money was $402.5 million, consisting of the notes. As of December 31, 2024, our subsidiaries had approximately $252.8 million of indebtedness and other liabilities (including trade payables, but excluding intercompany obligations and liabilities of a type not required to be reflected on a balance sheet of such subsidiaries in accordance with U.S. GAAP) to which the notes would have been structurally subordinated. The indenture governing the notes does not limit the amount of debt or other liabilities that we or our current or future subsidiaries may incur. Book-entry Form The notes are issued in book-entry form and are represented by permanent global certificates deposited with, or on behalf of, The Depository Trust Company, or DTC, and registered in the name of a nominee of DTC. Beneficial interests in any of the notes are shown on, and transfers will be effected only through, records maintained by DTC or its nominee and any such